Kort om
Spesialiserer seg på problemstillinger knyttet til ansvarlig kunnskapsbasert beslutningstaking med fokus på risiko og sikkerhet ved medisiner og ny bioteknologi, både fra et praktisk, metodisk og filosofisk perspektiv. Jobber tverrfaglig mellom vitenskapelig bevis, praksis og filosofi. Forskning inkluderer årsaksvurdering i legemiddelsikkerhet, klinisk resonnement, analyse av ekspertens uenighet.
Fagområder
Emner
Klinisk kommunikasjon Beslutningsprosesser Bivirkninger Legemiddelovervåkning Helsekompetanse
Forskningsgrupper
Forskningsprosjekter
Aktive forskningsprosjekter
-
Kausalitet, kompleksitet og evidens i pharmacovigilance
Å oppdage ukjende biverknader av marknadsførte legemiddel er utfordrande og krev forbetra metodar for å vurdere årsakssamanheng, og dessutan betre klinisk evidensgrunnlag.
Publikasjoner og forskningsresultater
Vitenskapelige publikasjoner
Garmann, Tahmineh; Samdal, Hilde; Sartori, Daniele;
Jahanlu, David
; Andersen, Fredrik;
Rocca, Elena
(2025).
Strategies and Challenges in Coding Ambiguous Information Using MedDRA®: An Exploration Among Norwegian Pharmacovigilance Officers.
Drug Safety.
https://doi.org/10.1007/s40264-025-01573-2
Andersen, Fredrik; Anjum, Rani Lill;
Rocca, Elena
(2025).
When Decisions Must be Based on Partial Causal Knowledge: Analyzing Causality and Evidence for Health Policy.
illary, phyllis; Russo, Federica (Red.).
The Routledge Handbook of Causality and Causal Methods. s. 493-506.
Routledge.
https://doi.org/10.4324/9781003528937-56
Anjum, Rani Lill;
Rocca, Elena
(2024).
A Dispositional Account of Causation: Implications for the Biological Sciences.
Yafeng, Shan; Shan, Yafeng (Red.).
Alternative Approaches to Causation: Beyond Difference-Making and Mechanism. s. 95-121.
Oxford University Press.
https://doi.org/10.1093/oso/9780192863485.003.0005
Leblanc, Marissa Erin; Williamson, Jon; Pretis, Francesco De; Landes, Jurgen;
Rocca, Elena
(2024).
Individual consent in cluster randomised trials for non-pharmaceutical interventions: going beyond the Ottawa statement.
Critical Public Health.
Vol. 34.
https://doi.org/10.1080/09581596.2024.2338074
Anjum, Rani Lill; Price, Christine;
Rocca, Elena
(2024).
When Patient Voices Get Lost in Evidence Hierarchies: A Testimony of Rare Adverse Events and Participatory Epistemic Injustice in Drug Safety Monitoring.
Social Epistemology.
https://doi.org/10.1080/02691728.2024.2400079
Rocca, Elena
; Pérez-González, Saul
(2023).
Evaluating the relevance of epidemiological studies for the single patient: How can evidence of mechanisms help?.
Journal of Evaluation In Clinical Practice.
Vol. 29.
https://doi.org/10.1111/jep.13859
Anjum, Rani Lill; Chandler, Rebecca;
Rocca, Elena
(2022).
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets.
Pharmaceutical Medicine.
Vol. 36.
https://doi.org/10.1007/s40290-022-00429-9
Pérez-González, Saul;
Rocca, Elena
(2022).
Evidence of Biological Mechanisms and Health Predictions: An Insight into Clinical Reasoning.
Perspectives in biology and medicine.
Vol. 65.
https://doi.org/10.1353/pbm.2022.0005
Rocca, Elena
; Grundmark, Birgitta
(2021).
Monitoring the Safety of Medicines and Vaccines in Times of Pandemic: Practical, Conceptual, and Ethical Challenges in Pharmacovigilance.
Argumenta.
Vol. 7.
https://doi.org/10.14275/2465-2334/202113.roc
Rocca, Elena
; Gauffin, Oskar; Savage, Ruth; Vidlin, Sara Hedfors; Grundmark, Birgitta
(2021).
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
Drug Safety.
Vol. 44.
https://doi.org/10.1007/s40264-021-01091-x